MedAvail Holdings, Inc.
MDVL · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $1 | $11 | $11 |
| % Growth | -34.7% | -94.5% | -1% | – |
| Cost of Goods Sold | $0 | $0 | $11 | $10 |
| Gross Profit | $0 | $0 | -$0 | $1 |
| % Margin | 44% | 41.5% | -1.1% | 11.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $5 | $5 | $11 |
| SG&A Expenses | $4 | $5 | $7 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $2 | $0 |
| Other Operating Expenses | $0 | $0 | $4 | $1 |
| Operating Expenses | $5 | $5 | $11 | $13 |
| Operating Income | -$4 | -$5 | -$11 | -$11 |
| % Margin | -1,099.8% | -808.2% | -94.7% | -100.3% |
| Other Income/Exp. Net | -$1 | -$8 | -$0 | -$0 |
| Pre-Tax Income | -$5 | -$13 | -$11 | -$12 |
| Tax Expense | $0 | $5 | -$0 | $0 |
| Net Income | -$6 | -$17 | -$11 | -$12 |
| % Margin | -1,429.9% | -2,822.4% | -97.5% | -105.8% |
| EPS | -3.22 | -10.9 | -6.9 | -7.7 |
| % Growth | 70.5% | -58% | 10.4% | – |
| EPS Diluted | -3.22 | -10.9 | -6.9 | -7.57 |
| Weighted Avg Shares Out | 2 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 2 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $2 |
| EBITDA | -$5 | -$12 | -$11 | -$10 |
| % Margin | -1,214.6% | -1,998.1% | -94.6% | -84.7% |